Medicines-AstraZeneca-NovoNordisk-Grindex-Tyumen CPP-Biocodex

Valusal (Ketoprofen) 2.5% gel Derivatives of propionic acid

Ozempic is a self-injectable medication that contains the active ingredient, semaglutide. Previously, it has been prescribed ‘off label’ for weight loss, but it is licensed in the UK for treating type 2 diabetes. Semaglutide is available as a weight loss injection under the brand name Semavik.